Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging
Reference21 articles.
1. National Cancer Institute Surveillance, Epidemiology, and End Results Program. https://seer.cancer.gov/. Accessed 20 Jan 2020.
2. Manus MPM, Hicks RJ, Matthews JP, McKenzie A, Rischin D, Salminen EK, et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non–small-cell lung cancer. J Clin Oncol. 2003;21:1285–92.
3. Shang J, Ling X, Zhang L, Tang Y, Xiao Z, Cheng Y, et al. Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2016;43:1945–53.
4. Castello A, Toschi L, Rossi S, Finocchiaro G, Grizzi F, Mazziotti E, et al. Predictive and prognostic role of metabolic response in patients with stage III NSCLC treated with neoadjuvant chemotherapy. Clin Lung Cancer. 2020;21:28–36.
5. Ding Q, Cheng X, Yang L, Zhang Q, Chen J, Li T, et al. PET/CT evaluation of response to chemotherapy in non-small cell lung cancer: PET Response Criteria in Solid Tumors (PERCIST) versus response evaluation criteria in solid tumors (RECIST). J Thorac Dis. 2014;6:677–83.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献